COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus

This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19 in immunocompromised patients, including persons with human immunodeficiency virus. It describes various preventive measures, including vaccines and their effectiveness and the role of monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakharia, Niyati, Subramanian, Aruna K., Shapiro, Adrienne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/
https://www.ncbi.nlm.nih.gov/pubmed/35636907
http://dx.doi.org/10.1016/j.idc.2022.01.006
_version_ 1784643379789824000
author Jakharia, Niyati
Subramanian, Aruna K.
Shapiro, Adrienne E.
author_facet Jakharia, Niyati
Subramanian, Aruna K.
Shapiro, Adrienne E.
author_sort Jakharia, Niyati
collection PubMed
description This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19 in immunocompromised patients, including persons with human immunodeficiency virus. It describes various preventive measures, including vaccines and their effectiveness and the role of monoclonal antibodies for pre-exposure prophylaxis. It also reviews the different treatment options for immunocompromised individuals, including antivirals, monoclonal antibodies, and immunomodulators. Lastly, it describes the impact of COVID-19 on transplantation and continuity care of this population.
format Online
Article
Text
id pubmed-8806148
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88061482022-02-02 COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus Jakharia, Niyati Subramanian, Aruna K. Shapiro, Adrienne E. Infect Dis Clin North Am Article This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19 in immunocompromised patients, including persons with human immunodeficiency virus. It describes various preventive measures, including vaccines and their effectiveness and the role of monoclonal antibodies for pre-exposure prophylaxis. It also reviews the different treatment options for immunocompromised individuals, including antivirals, monoclonal antibodies, and immunomodulators. Lastly, it describes the impact of COVID-19 on transplantation and continuity care of this population. Elsevier Inc. 2022-06 2022-02-01 /pmc/articles/PMC8806148/ /pubmed/35636907 http://dx.doi.org/10.1016/j.idc.2022.01.006 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jakharia, Niyati
Subramanian, Aruna K.
Shapiro, Adrienne E.
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
title COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
title_full COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
title_fullStr COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
title_full_unstemmed COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
title_short COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
title_sort covid-19 in the immunocompromised host, including people with human immunodeficiency virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/
https://www.ncbi.nlm.nih.gov/pubmed/35636907
http://dx.doi.org/10.1016/j.idc.2022.01.006
work_keys_str_mv AT jakharianiyati covid19intheimmunocompromisedhostincludingpeoplewithhumanimmunodeficiencyvirus
AT subramanianarunak covid19intheimmunocompromisedhostincludingpeoplewithhumanimmunodeficiencyvirus
AT shapiroadriennee covid19intheimmunocompromisedhostincludingpeoplewithhumanimmunodeficiencyvirus

Ejemplares similares